Boston Scientific (BSX) Other Operating Expenses (2009 - 2026)

Boston Scientific has disclosed Other Operating Expenses across 17 years of filings, most recently posting $213.0 million for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $213.0 million, down 10.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 8.63% YoY), and the FY2025 annual result was $1.2 billion, changed N/A from the prior year.
• Other Operating Expenses came in at $213.0 million for Q1 2026 at Boston Scientific, down from $435.0 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $500.0 million in Q2 2024 to a low of -$22.0 million in Q4 2022.
• The 5-year median for Other Operating Expenses is $246.5 million (2023), against an average of $264.4 million.
• Across the five-year window, Other Operating Expenses tumbled 173.33% in 2022 and jumped 1250.0% in 2023, its largest moves.
• Boston Scientific's Other Operating Expenses stood at -$22.0 million in 2022, then surged by 1250.0% to $253.0 million in 2023, then soared by 42.69% to $361.0 million in 2024, then advanced by 20.5% to $435.0 million in 2025, then tumbled by 51.03% to $213.0 million in 2026.
• The last three Other Operating Expenses figures came in at $213.0 million (Q1 2026), $435.0 million (Q4 2025), and $247.0 million (Q3 2025), per Business Quant data.